Literature DB >> 22775062

Effect of hyperbaric oxygen on Vibrio vulnificus and murine infection caused by it.

Tetsuro Tamura1, Ken-ichiro Iida, Mitsumasa Saito, Susumu Shiota, Hiroaki Nakayama, Shin-ichi Yoshida.   

Abstract

Vibrio vulnificus is a bacterium known to cause fatal necrotizing soft tissue infection in humans. Here, a remarkable therapeutic effect of hyperbaric oxygen (HBO) on V. vulnificus infection provoked by its injection into mouse footpads is described. HBO was shown to be bactericidal to this bacterium in vitro as well as in the infected tissue. The bactericidal activity of HBO was shown to be due to reactive oxygen species (ROS), the efficacy of HBO against V. vulnificus infection being accounted for by the high sensitivity of this bacterium to ROS. Besides being somewhat weak in ROS-inactivating enzyme activities, this bacterium is also unusually sensitive to ultraviolet light and other DNA-damaging agents. It seems likely that the sensitivity of V. vulnificus to HBO is mainly due to its poor ability to repair oxidative damage to DNA. These findings encourage clinical application of HBO against potentially fatal V. vulnificus infection in humans.
© 2012 The Societies and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22775062     DOI: 10.1111/j.1348-0421.2012.00491.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  2 in total

Review 1.  Effect of elevated oxygen concentration on bacteria, yeasts, and cells propagated for production of biological compounds.

Authors:  Antonino Baez; Joseph Shiloach
Journal:  Microb Cell Fact       Date:  2014-12-19       Impact factor: 5.328

2.  Septic Shock Induced by Vibrio Vulnificus in Northern Poland, a Case Report.

Authors:  Bogusz Jan Aksak-Wąs; Agnieszka Ripa; Paweł Szakoła; Karolina Horbacka; Jolanta Niścigorska-Olsen; Magdalena Witak-Jędra; Małgorzata Zając-Marczewska; Malwina Karasińska-Cieślak; Jacek Kot; Miłosz Parczewski
Journal:  Infect Drug Resist       Date:  2021-11-30       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.